Published in Am J Gastroenterol on March 01, 1983
The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg (1990) 1.48
Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.30
Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart (1998) 1.27
Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report. World J Surg Oncol (2008) 1.06
Differences between endocarditis caused by Streptococcus bovis and Enterococcus spp. and their association with colorectal cancer. Eur J Clin Microbiol Infect Dis (2015) 0.84
Infective Endocarditis and Cancer Risk: A Population-Based Cohort Study. Medicine (Baltimore) (2016) 0.77
Rapid identification of Streptococcus bovis by using combination constitutive enzyme substrate hydrolyses. J Clin Microbiol (1989) 0.76
Streptococcus sanguis endocarditis associated with colonic carcinoma. BMJ Case Rep (2010) 0.75
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Changes in contractile properties of disused soleus muscles. J Physiol (1969) 2.09
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39
Aging differentially alters forms of long-term potentiation in rat hippocampal area CA1. J Neurophysiol (1998) 1.36
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29
Neuromuscular transmission and correlative morphology in young and old mice. J Physiol (1983) 1.28
Effect of chronic disuse of rat soleus neuromuscular junctions on postsynaptic membrane. J Neurophysiol (1971) 1.28
Ultrastructural studies of young and old mouse neuromuscular junctions. J Neurocytol (1982) 1.26
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23
Infectious diarrhea in patients with AIDS. Dig Dis Sci (1988) 1.22
Physiological studies during formation and development of rat neuromuscular junctions in tissue culture. J Gen Physiol (1971) 1.22
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol (1997) 1.16
Cell proliferation in denervated muscle: identity and origin of dividing cells. Neuroscience (1982) 1.13
High testicular salvage rate in torsion of the spermatic cord. J Urol (1982) 1.11
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11
Biological action of inosine analogs in Leishmania and Trypanosoma spp. Antimicrob Agents Chemother (1984) 1.11
Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr (2001) 1.10
Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med (1983) 1.10
Histochemical and contractile properties in the cross-innervated guinea pig soleus muscle. Arch Neurol (1969) 1.10
Reactions of cytosine derivatives with acidic buffer solutions. II. Studies on transamination, deamination, and deuterium exchange. Biochemistry (1967) 1.08
Developing neuromuscular junctions: first signs of chemical transmission during formation in tissue culture. Science (1971) 1.08
Lack of association of Streptococcus bovis with noncolonic gastrointestinal carcinoma. Am J Gastroenterol (1987) 1.06
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med (2001) 1.06
Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagn Microbiol Infect Dis (1987) 1.05
Nucleosides. 73. Ribosyl analogs of chloramphenicol. J Org Chem (1971) 1.05
Cell proliferation in denervated muscle: time course, distribution and relation to disuse. Neuroscience (1982) 1.05
Effect of chronic disuse of rat soleus neuromuscular junctions on presynaptic function. J Neurophysiol (1971) 1.03
Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer (1994) 1.03
An effective hospital-based pneumococcal immunization program. Arch Intern Med (1986) 1.02
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02
Differences in neuromuscular transmission in red and white muscles. Brain Res (1978) 1.01
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol (2001) 1.01
A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Mycobacterium gordonae in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.00
Persistent fever in association with infective endocarditis. Clin Infect Dis (1992) 1.00
Activity of inosine analogs against Pneumocystis carinii in culture. Antimicrob Agents Chemother (1986) 1.00
Pyomyositis caused by Yersinia enterocolitica. J Clin Microbiol (1984) 1.00
Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis (1998) 1.00
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Gender differences in HIV risk behaviors in an adult emergency department in New York City. J Urban Health (1999) 0.99
The role of the nerve in maintenance of frog taste buds. Exp Neurol (1967) 0.99
Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection. J Infect Dis (2000) 0.98
Cation movements in normal and short-term denervated rat fast twitch muscle. J Physiol (1977) 0.98
Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med (2006) 0.97
The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2001) 0.97
Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol (1991) 0.96
Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis (2003) 0.96
Nucleosides. 78. Synthesis of some 6-substituted uracils and uridines by the Wittig reaction. J Org Chem (1972) 0.95
Investigation of possible cholinergic mechanisms in fertilization of Xenopus eggs. Proc R Soc Lond B Biol Sci (1981) 0.95
Additional evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS (1990) 0.95
Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome. J Immunol (1985) 0.95
Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats. Antimicrob Agents Chemother (1994) 0.95
Scanning and light microscopic study of age changes at a neuromuscular junction in the mouse. J Neurocytol (1983) 0.94
Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients. Ophthalmology (1983) 0.94
Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS (1999) 0.93
Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-beta-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. J Med Chem (1983) 0.93
Progression of age changes in synaptic transmission at mouse neuromuscular junctions. J Physiol (1983) 0.92
Rates of and factors associated with self-reported prior HIV testing among adult medical patients in an inner city emergency department in the Bronx, New York City. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92
Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA (1986) 0.91
Body image in older men with or at-risk for HIV infection. AIDS Care (2007) 0.90
Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Med Oncol (1999) 0.90
Progression of age changes in mature mouse motor nerve terminals and its relation to locomotor activity. J Neurocytol (1985) 0.90
Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group. Am J Med (1998) 0.89
Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS (2001) 0.89
Regional variation in CCR5-Delta32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes Immun (2002) 0.88